Drug Shortage Report for INSPRA
Report ID | 50675 |
Drug Identification Number | 02323060 |
Brand name | INSPRA |
Common or Proper name | INSPRA |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | EPLERENONE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 3 x 10 TABS |
ATC code | C03DA |
ATC description | POTASSIUM-SPARING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-07-09 |
Estimated end date | |
Actual end date | 2018-07-19 |
Shortage status | Resolved |
Updated date | 2018-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-07-20 | French | Compare |
v11 | 2018-07-20 | English | Compare |
v10 | 2018-07-20 | English | Compare |
v9 | 2018-07-10 | English | Compare |
v8 | 2018-07-09 | French | Compare |
v7 | 2018-07-09 | English | Compare |
v6 | 2018-07-07 | English | Compare |
v5 | 2018-06-27 | French | Compare |
v4 | 2018-06-27 | English | Compare |
v3 | 2018-06-20 | English | Compare |
v2 | 2018-05-29 | French | Compare |
v1 | 2018-05-29 | English | Compare |
Showing 1 to 12 of 12